A novel mutation in bruton tyrosine kinase confers acquired resistance to ibrutinib (PCI-32765) in CLL Meeting Abstract
| Authors: | Furman, R. R.; Cheng, S.; Lu, P.; Setty, M.; Perez, A.; Guo, A.; Racchumi, J.; Ma, J.; Coleman, M.; Venkataraman, K.; Xu, G.; Chen, W.; Wu, H.; Chang, B. Y.; Leslie, C.; Wang, Y. L. |
| Abstract Title: | A novel mutation in bruton tyrosine kinase confers acquired resistance to ibrutinib (PCI-32765) in CLL |
| Meeting Title: | 103rd Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) |
| Journal Title: | Laboratory Investigation |
| Volume: | 94 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2014 Mar 1-7 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0023-6837 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2014-02-01 |
| Start Page: | 347A |
| Language: | English |
| ACCESSION: | WOS:000331155801647 |
| PROVIDER: | wos |
| DOI: | 10.1038/labinvest.2014.26 |
| Notes: | Meeting Abstract: 1429 -- 103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) -- MAR 01-07, 2014 -- San Diego, CA -- 1 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
